A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study

The present study was aimed at defining the antitumour activity of the cisplatin-paclitaxel-topotecan (CPT) weekly administration with G-CSF support in chemo-naive SCLC patients with extensive disease (ED-SCLC). Chemonaive ED-SCLC patients received cisplatin 40 mg/m2, paclitaxel 85 mg/m2, and topotecan 2.25 mg/m2weekly, with G-CSF (5 μg/kg days 3–5) support, for a maximum of 12 weeks. 37 patients were treated, for a total of 348 cycles delivered. 8 complete responses (22%) and 22 partial responses (59%) were recorded, giving an 81% [95% CI = 65–92%] ORR. At a 13-month (range, 4–26) median follow-up, median progression-free and overall survival were 8 months and 12.5 months, with 1-year and 2-year projected survivals of 55% and 21%, respectively. No toxic deaths occurred. Grade 4 neutropenia and thrombocytopenia occurred in 6 and 3 patients, respectively. Only one case of neutropenic sepsis was recorded, while haemorrhagic thrombocytopenia was never observed. Diarrhoea, paraesthesias and fatigue were the main nonhaematologic toxicities being severe in 6, 2 and 10 patients, respectively. The weekly CPT combination with G-CSF support represents a well tolerated therapeutic approach in chemo-naive ED-SCLC patients. The activity rate seems at least similar to that achievable with the standard front-line approaches. © 2001 Cancer Research Campaign http://www.bjcancer.co

Evolución de la flexibilidad de la cadena cinética posterior en escolares de 5 a 11 años

La finalitat del nostre estudi és valorar l’evolució de la flexibilitat de la cadena cinètica posterior en els escolars de 5 a 11 anys, i observar en quins grups d’edat és necessària l’aplicació de programes específics per a millorar-la. Els escolars varen ser sotmesos a les mateixes valoracions: el test de “sit and reach”, la pressa de les mesures antropomètriques, altura i pes, i el qüestionari Minesotta sobre el consum calòric en el temps de lleure. Dels resultats es desprèn que a mesura que augmenta l’edat, la flexibilitat dels escolars estudiats disminueix progressivament. Existeix un interval d’edat situat en els 9 anys que sembla marcar un canvi de tendència en la flexibilitat dels escolars. És a partir d’aquesta edat quan el grau de flexibilitat disminueix de forma significativa i, es més marcada entre els nens, sent necessària una intervenció més específica en ells

Programa de intervención específico para la mejora de la flexibilidad en escolares: es efectiva la intervención del MEF?

La finalitat del nostre va ser valorar l’aplicació d’un programa d’intervenció específic per a millorar la flexibilitat en un grup d’escolars de 9 anys. Van ser inclosos en l’estudi 63 escolars de 4º curs d’Educació Primària, del Centre Escolar la Salle i el CEIP St. Ignasi, ambdós de Manresa (Barcelona). Durant tres setmanes, el centre La Salle va aplicà un programa específic per a millorar la flexibilitat de la cadena cinètica posterior. En canvi, el CEIP St. Ignasi es va utilitzar com a grup control, continuant el seu programa educatiu habitual. Hem observat que l’aplicació de programes específics per a millorar la flexibilitat és efectiva en los escolares de 9 anys. La forma de aplicar els programes de educació física modifica significativament el grau de flexibilitat en los escolares

Efectes de l'abstinència tabàquica sobre la termoregulació durant l'activitat física

La situació de fumador actiu 1 hora abans de la pràctica d’activitat física pot alterar la resposta termoreguladora, comprometen de forma significativa els mecanismes vasodilatadors cutànis de pèrdua de calor i provocar una resposta hemodinàmica anormal durant l’exercici. L’efecte additiu de la nicotina i de l’activitat física d’alta intensitat pot fer augmentar la temperatura central al pertorbar els mecanismes de pèrdua de calor mitjançant la redistribució del flux vascular cutani. A més, durant exercicis perllongats com els exercicis de resistència, i en ambients calorosos, el consum actiu de cigarretes podria actuar com a factor limitant en el rendiment esportiu, i poder incrementar el risc d’induir hipertèrmia

Efectes de l'hàbit tabàquic sobre la termoregulació durant l'activitat física

El fumar cigarretes, a un ritme habitual i sense evitar el seu consum les hores prèvies a l’activitat física, pot comprometre de forma significativa els mecanismes termoreguladors de pèrdua de calor i provocar una resposta hemodinàmica anormal durant l’exercici. L’associació de tabac i activitat física d’alta intensitat pot fer augmentar la temperatura central al pertorbar els mecanismes de pèrdua de calor mitjançant la redistribució del flux vascular cutani. A més, durant exercicis perllongats com els exercicis de resistència, i en ambients alorosos, el consum de cigarretes pot actuar com a factor limitant en el rendiment esportiu, i incrementar el risc d’hipertèrmia

Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapy

n/

Fuerza prensil de la mano asociada al grado de autonomía y riesgo de caída en ancianos

Objetivo: Determinación de la fuerza de prensión de la mano como indicador de la capacidad funcional y grado de autonomía para actividades cotidianas en personas de la tercera edad. Diseño: Se realizó un estudio observacional de diseño transversal. Emplazamiento: Medio comunitario. Centros cívicos, centros culturales y residencias de la tercera edad de la comarca del Bages (Barcelona). 2 Participantes: Se estudió a 61 personas, 40 mujeres y 21 hombres, con un rango de edad comprendido entre los 65 y 90 años, quienes no presentaban afecciones invalidantes graves. Se solicitó su colaboración y aceptación voluntaria tras informar del objetivo del estudio. Mediciones principales: El grado de autonomía funcional se valoró mediante el test de Barthel y el test de Lawton-Brody, y el riesgo de caída mediante el test de Tinetti. La fuerza muscular máxima voluntaria (FMMV) se determinó mediante el test de prensión de la mano (handgrip). Resultados: Los hombres mostraron una correlación positiva y estadísticamente significativa (p=0.001) entre la fuerza prensil de la mano y el grado de autonomía funcional y el menor riesgo de caída (p=0.037). Dicha correlación no fue observada en las mujeres respecto al grado de autonomía (p=0.232) y fue escasa para el riesgo de caída (p=0.048). Conclusiones: El test de handgrip es una herramienta potencialmente útil para estimar la autonomía funcional e instrumental y el riesgo de caídas, especialmente en varones que sobrepasan los 65 años.Objective: To determine the hand strength as an indicator of functional ability and degree of autonomy in activities of daily living for older people. Design: An observational study of transversal design. Setting: Community setting. Civic centres, cultural centres and residences of the third age of the region of the Bages (Barcelona). Participants: We studied 61 subjects, 40 women and 21 men, age 65 to 90 years, who had no serious disabling conditions. Requested his collaboration and voluntary acceptance after informing of the aim of the study. Main measurements: The degree of functional autonomy was assessed by the Barthel and Lawton-Brody test, and the risk of falling through the Tinetti test. The maximum voluntary hand strength was determined by the handgrip test. Results: Men showed a statistically significant positive correlation (p = 0.001) between the handgrip strength and the degree of functional autonomy and a reduced risk of falling (p = 0.037). This correlation was not observed in women on the degree of autonomy (p = 0.232) and was limited to the risk of falling (p = 0.048). Conclusions: The handgrip test is a potentially useful tool to estimate the functional and instrumental autonomy and the risk of falls, especially in men older of 65 years

Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients

The aim of the present study was to define the activity and tolerability of a triplet regimen including oxaliplatin 130 mg m−2 (2 h i.v. infusion) and raltitrexed 3.0 mg m−2 (15 min i.v. infusion) given on day 1, followed by levo-folinic acid 250 mg m−2 (2 h i.v. infusion) and 5-fluorouracil 1050 mg m−2 i.v. bolus on day 2, every 2 weeks, in pretreated colorectal cancer patients. From April 1999 to December 2000, 50 patients were enrolled: 26 were males and 24 females, their median age was 63 (range, 43–79) years; ECOG performance status was 0 in 26 patients, ⩾1 in 24 patients; 26 patients had received previous adjuvant chemotherapy, 40 patients had been exposed to one or two lines of palliative chemotherapy (including irinotecan in 31 cases); 18 patients were considered chemo-refractory. A total of 288 cycles were administered, with a median number of 6 (range 1–12) courses per patient. A complete response was obtained in three patients, and a partial response in nine patients, giving a major response rate of 24% (95% confidence interval, 13–38%), while 15 further patients showed a stable disease, for an overall control of tumour growth in 60% of patients. Three complete responses and three partial responses were obtained in patients pretreated with irinotecan (response rate, 19%); among refractory patients, three achieved partial responses (response rate, 13%). After a median follow-up of 18 (range, 10–30) months, 40 patients showed a progression of disease: the growth modulation index ranged between 0.2 and 2.5: it was ⩾1.33 (showing a significant delay of tumour growth) in 16 (40%) patients. Actuarial median progression-free survival time was 7.6 months, and median survival time was 13.6 months: estimated probability of survival was 55% at 1 year. Main severe toxicity was neutropenia: World Health Organisation grade 4 affected 32% of patients; non-haematological toxicity was mild: World Health Organisation grade 3 diarrhoea was complained of by 8%, and grade 3 stomatitis by 4% of patients; neurotoxicity (according to Lévi scale) was scored as grade 3 in 8% of patients. In conclusion, this regimen was manageable and active as salvage treatment of advanced colorectal cancer patients; it showed incomplete cross-resistance with irinotecan-based treatments, and proved to delay the progression of disease in a relevant proportion of treated patients

Concomitant MPZ and MFN2 Gene Variants and Charcot Marie Tooth Disease in a Boy: Clinical and Genetic Analysis-Literature Review

: Charcot- Marie- Tooth (CMT) disease includes a group of clinically and genetically heterogeneous neuropathic disorders with an estimated frequency of 1 on 2.500 individuals. CMTs are differently classified according to the age of onset, type of inheritance, and type of inheritance plus clinical features. For these disorders, more than 100 genes have been implicated as causal factors, with mutations in the PMP22 being one of the most common. The demyelinating type (CMT1) affects more than 30% of the CMTs patients and manifests with motor and sensory dysfunctions of the peripheral nervous system mainly starting with slow progressive weakness of the lower extremities. We report here a 12 year- old boy presenting with typical features of CMT1 type, hearing impairment, and inguinal hernia who at the next-generation sequence analysis displayed a concomitant presence of two variants: the c.233 C>T p.Ser 78Leu of the MPZ gene (NM_000530.6) characterized as pathogenetic and the c.1403 G>A p.Arg 468His of the MFN2 gene (NM_014874.3) characterized as VUS. Concomitant variant mutations in CMTs have been uncommonly reported. The role of these gene mutations on the clinical expression and a literature review on this topic is discussed